ArticleComputational and structural biotechnology journal2025
RNA-seq-derived sequence variations are excellent features for cell line identification.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cell lines are indispensable models for analyzing molecular mechanisms underlying human diseases. However, incorrect annotation and cross-contamination can introduce severe bias in respective studies. Accordingly, various publishers request authentication of cell lines before publication. Short tandem repeat profiling is commonly used to verify cell line identity and purity but does not guarantee that published results are based on the samples tested by this method. In this study, we demonstrate that RNA-seq-derived sequence variation information is eligible for unambiguous cell line-specific clustering. Based on this finding, we propose methods for reliable cell line identification from RNA-seq data using supervised machine learning methods. In addition, we demonstrate the ability to detect cross-contamination of human cell lines. The presented methods are insensitive to different data pre-processing steps and quality measures. The proposed topFracCCLE algorithm for cell line identification and detection of cross-contamination is available as R-script at https://github.com/HuettelmaierLab/topFracCCLE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.